References - Neonatal Intensive Care Drug Manual

1. Baud O, Maury L, Lebail F, Ramful D, El Moussawi F, Nicaise C, Zupan-Simunek V, Coursol A, Beuchee A, Bolot P, Andrini P, Mohamed D, Alberti C, group Pts. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial. Lancet. 2016;387:1827-36.
2. Baud O, Trousson C, Biran V, Leroy E, Mohamed D, Alberti C, Group PT. Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age. JAMA. 2017;317:1329-37.
3. Doyle LW, Cheong JL, Ehrenkranz RA, Halliday HL. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. The Cochrane database of systematic reviews. 2017;10:CD001146.
4. Ng PC, Lam CW, Lee CH, Chan IH, Wong SP, Fok TF. Suppression and recovery of the hypothalamic function after high-dose corticosteroid treatment in preterm infants. Neonatology. 2008;94:170-5.
5. Ng PC, Lee CH, Bnur FL, Chan IH, Lee AW, Wong E, Chan HB, Lam CW, Lee BS, Fok TF. A double-blind, randomized, controlled study of a "stress dose" of hydrocortisone for rescue treatment of refractory hypotension in preterm infants. Pediatrics. 2006;117:367-75.
6. Walther FJ, Findlay RD, Durand M. Adrenal suppression and extubation rate after moderately early low-dose dexamethasone therapy in very preterm infants. Early Human Development. 2003;74:37-45.
7. Ibrahim H, Sinha IP, Subhedar NV. Corticosteroids for treating hypotension in preterm infants. The Cochrane database of systematic reviews. 2011:CD003662.
8. Doyle LW, Ehrenkranz RA, Halliday HL. Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology. 2010;98:111-7.
9. Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2016;101:364-89.
10. Rahmah R, Hayati AR, Kuhnle U. Management and short-term outcome of persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis). Singapore Medical Journal. 1999;40:151-6.
11. Sotelo-Cruz N, Cordero-Olivares A, Ramirez-Rodriguez C, Lopez-Cervantes G, Hurtado-Valenzuela J, Lopez-Cervantes BM. [Persistent hyperinsulinemic hypoglycemia. Two case reports]. Cirugia y Cirujanos. 2004;72:409-14.
12. Peltoniemi O, Kari MA, Heinonen K, Saarela T, Nikolajev K, Andersson S, Voutilainen R, Hallman M. Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants. The Journal of pediatrics. 2005;146:632-7.
13. Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC, Couser RJ, Garland JS, Rozycki HJ, Leach CL, Backstrom C, Shaffer ML. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics. 2004;114:1649-57.
14. Salas G, Travaglianti M, Leone A, Couceiro C, Rodriguez S, Farina D. [Hydrocortisone for the treatment of refractory hypotension: a randomized controlled trial]. Anales de pediatria. 2014;80:387-93.
15. Cranny RL, Kirschvink JF, Kelley VC. The half-life of hydrocortisone in normal newborn infants. AMA journal of diseases of children. 1960;99:437-43.
16. Vezina HE, Ng CM, Vazquez DM, Barks JD, Bhatt-Mehta V. Population pharmacokinetics of unbound hydrocortisone in critically ill neonates and infants with vasopressor-resistant hypotension. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2014;15:546-53.
17. Baker CF, Barks JD, Engmann C, Vazquez DM, Neal CR, Jr., Schumacher RE, Bhatt-Mehta V. Hydrocortisone administration for the treatment of refractory hypotension in critically ill newborns. Journal of perinatology : official journal of the California Perinatal Association. 2008;28:412-9.
18. Mizobuchi M, Yoshimoto S, Nakao H. Time-course effect of a single dose of hydrocortisone for refractory hypotension in preterm infants. Pediatrics international : official journal of the Japan Pediatric Society. 2011;53:881-6.
19. Sydney Children’s Hospital Network. Adrenal Insufficiency – Emergency Management. Guideline No: 0/C/14:9017-01:00
20. Australian Injectable Drugs Handbook, 6th Edition, Society of Hospital Pharmacists of Australia 2014
20. Micromedex Online. Accessed on 28th October 2015.
|